Catalyst Wire Dossier Catalyst Wire Dossier

Unspecified enkephalinergic agonist

· AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unspecified enkephalinergic agonist, covering 2012-11-08 to 2012-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD) [Phase 2]

See pricing